Molecular mechanisms of muscle atrophy in myotonic dystrophies.
about
Fragile X-associated tremor/ataxia syndrome.Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblastsGenome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I.Serum response factor regulates smooth muscle contractility via myotonic dystrophy protein kinases and L-type calcium channelsPentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.Abnormal Lactate Levels Affect Motor Performance in Myotonic Dystrophy Type 1.(CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis.Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells.Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog.Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1.CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing.Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models.
P2860
Q26852667-B811CD3E-1C6D-4CC6-A8AE-8CE2D866ABCDQ30830556-B6C0E67C-BF31-436F-AEBC-F7EC13CB2017Q35145526-E07F463B-1566-4401-B9AF-541785C800B1Q35818784-917E7D14-16C1-4E09-9188-E8C8801C2B24Q36151477-66F9924B-9050-42F5-9367-B39D7A8C8D90Q36268077-49A7F5FC-F2C3-441F-810A-11C98E9B36A7Q36506541-AFF0F8BB-5BCE-4226-A7BD-2595F05F805DQ37590150-86270702-721F-48C5-9C8F-58E8D36CF476Q38347349-B0DFE64E-64BF-4D6E-A2C1-B40B43FD72E2Q38721747-1267187C-6480-4721-901D-92FC9711528EQ38753115-A977C7D1-75EC-4C58-AA33-61EB09E8E588Q38860146-B070A4A6-050D-4830-849E-217673A8D776Q47332454-A762C603-BA53-47BF-8461-8F14F27165C4Q48854625-80965AFB-A63B-4822-9DFB-F4E9C5F8B8D6Q54982478-15CF9ADD-960B-4540-A484-52D622DBF05BQ55418837-44F98041-A5C0-43A5-B488-5894E0A9F22E
P2860
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
@en
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
@nl
type
label
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
@en
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
@nl
prefLabel
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
@en
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
@nl
P2860
P1476
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
@en
P2093
Lubov Timchenko
P2860
P304
P356
10.1016/J.BIOCEL.2013.06.010
P577
2013-06-21T00:00:00Z